Cellectis SA (CLLS)
3.41
+0.03
(+0.89%)
USD |
NASDAQ |
Apr 02, 16:00
3.49
+0.08
(+2.35%)
After-Hours: 20:00
Cellectis Market Cap : 354.18M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| DBV Technologies SA | 1.191B |
| EDAP TMS SA | 121.66M |
| Sanofi | 117.17B |
| Akari Therapeutics Plc | 5.116M |
| Biodexa Pharmaceuticals Plc | 1.057M |
Market Cap Related Metrics
| PS Ratio | 4.700 |
| PEG Ratio | -0.0621 |
| Price to Book Value | 4.519 |
| Price | 3.41 |
| Earnings Yield | -19.86% |
| PEGY Ratio | -0.0621 |